Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages.
Among 125 clinical isolates of Mycobacterium tuberculosis collected in Hong Kong and Shanghai, China, between 2002 and 2004, IS6110 typing revealed that 71 strains (57%) belonged to the Beijing family. The intracellular growth of the strains in human peripheral blood monocyte-derived macrophages was measured ex vivo on days 0, 3, 6, and 10. Among all tested strains, three hypervirulent strains showed significant increases in intracellular growth after 10 days of incubation. With an initial bacterial load of 10(4) CFU, most of the clinical isolates and H37Ra (an avirulent strain) exhibited no intracellular survival on day 10, while the three hypervirulent strains together with H37Rv (a virulent strain) showed on average a two- to fourfold rise in CFU count. These three hypervirulent strains belonging to a non-Beijing family were isolated from patients suffering from tuberculosis meningitis. Cytokines secreted by gamma interferon-activated macrophages were measured daily after challenge with selected strains of M. tuberculosis. The levels of tumor necrosis factor alpha were elevated after 24 h of infection among all strains, but the levels were significantly lower among the three hypervirulent strains, whereas interleukin 10 (IL-10) and IL-12 were not detected. Results were concordant with the differential expression of the corresponding cytokine genes in activated macrophages, as monitored by real-time PCR. Our findings highlighted that these three hypervirulent strains may possess an innate mechanism for escaping host immunity, which accounts for their characteristic virulence in patients presenting with a more severe form of disease.
Wong
K C
KC
Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
Leong
W M
WM
Law
H K W
HK
Ip
K F
KF
Lam
J T H
JT
Yuen
K Y
KY
Ho
P L
PL
Tse
W S
WS
Weng
X H
XH
Zhang
W H
WH
Chen
S
S
Yam
W C
WC
D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D015964:Gene Expression Regulation, Bacterial / Q000276:immunology; D006801:Humans; D008264:Macrophages / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology*; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification* / Q000472:pathogenicity*; D010641:Phenotype; D012150:Polymorphism, Restriction Fragment Length; D014774:Virulence
D016207:Cytokines
AIDS Res Ther. 2006 Mar 31;3:8
16573838
J Clin Microbiol. 1993 Aug;31(8):1987-95
7690367
J Immunol. 2001 Jun 15;166(12):7477-85
11390501
Clin Microbiol Rev. 2003 Jul;16(3):463-96
12857778
J Clin Microbiol. 1995 Dec;33(12):3234-8
8586708
J Clin Microbiol. 1993 Feb;31(2):406-9
8381814
Infect Immun. 1998 Jan;66(1):176-80
9423855
Clin Exp Immunol. 2003 Jul;133(1):30-7
12823275
Infect Immun. 2000 Jan;68(1):387-90
10603413
N Engl J Med. 2003 Sep 18;349(12):1149-56
13679530
Curr Opin Infect Dis. 2003 Jun;16(3):205-10
12821809
J Immunol Methods. 2002 Jun 1;264(1-2):95-108
12191514
J Clin Microbiol. 2002 Apr;40(4):1277-82
11923345
J Infect Dis. 2005 Feb 1;191(3):453-60
15633105
Clin Microbiol Rev. 2002 Apr;15(2):294-309
11932234
Curr Opin Infect Dis. 2004 Oct;17(5):397-403
15353958
Lancet Infect Dis. 2003 Jan;3(1):13-21
12505028
J Clin Microbiol. 2003 Jun;41(6):2706-8
12791911
N Engl J Med. 2001 Oct 11;345(15):1098-104
11596589
J Clin Microbiol. 2004 Sep;42(9):4040-9
15364987
J Clin Microbiol. 1994 Jan;32(1):262-6
7907344
Infect Immun. 1997 Nov;65(11):4620-3
9353042
J Infect Dis. 2000 Jul;182(1):240-51
10882603
Infect Immun. 2004 Apr;72(4):2067-74
15039328
J Clin Invest. 1997 May 15;99(10):2518-29
9153296
J Immunol. 1999 Mar 15;162(6):3504-11
10092807
Infect Immun. 1996 Apr;64(4):1351-6
8606100
J Immunol. 2002 Feb 1;168(3):1328-37
11801673
Infect Immun. 1998 Feb;66(2):794-9
9453643
Int J Tuberc Lung Dis. 2002 Aug;6(8):720-7
12150485